Search for a command to run...
Promoter shareholding increased by 1.60% YoY, contrasting with a 2.13% YoY decline in institutional holdings, indicating potential insider confidence amid broader institutional selling.
Both institutional and public shareholding in SMS Pharmaceuticals declined, suggesting a lack of confidence from smart money and retail investors, which is not aligned with sector averages showing stability.
In comparison to sector peers, SMS Pharmaceuticals is underperforming, particularly against SUDARSHAN, which saw a significant institutional increase of 18.88%.
| Category | Trend | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|
1Promoter9 | 64.3% | 64.3% | 64.66% | 64.66% | 64.66% | 64.66% | 66.26% | 66.26% | |
2Institution2 | - | - | 1.98% | 2.13% | 2.54% | 2.54% | 2.43% | - | |
3Public7 | 7.68% | 7.68% | 7.69% | 7.69% | 7.69% | 7.69% | 7.35% | 7.43% |